Contemporary management of infrarenal aortic graft infection: early and late results in 82 patients

Vascular ◽  
2012 ◽  
Vol 20 (3) ◽  
pp. 129-137 ◽  
Author(s):  
Michel Batt ◽  
Elixène Jean-Baptiste ◽  
Stephen O'Connor ◽  
Patrick Feugier ◽  
Stéphan Haulon

Management of aortic graft infection (AGI) remains contentious. The purpose of this study was to evaluate factors of clinical significance which influence the outcome of different treatment modalities for AGI. From 2000 to 2008, 82 consecutive patients were treated for AGI. In situ reconstruction (ISR) was performed in 63 patients with various conduits, extra-anatomic reconstruction (EAR) in 11, conservative treatment in five and resection without reconstruction in three. The perioperative mortality rate for the series (33%) was similar for EAR and ISR and was higher in patients with secondary aortoenteric fistula ( P < 0.001) in those undergoing emergency aortic reconstruction ( P < 0.001) and in AGI caused by virulent organisms ( P < 0.05). Fifteen (27%) of the surviving patients developed a recurrence of infection (RI). EAR patients were more exposed to RI ( P < 0.04). In conclusion, ISR may be more appropriate for AGI, but this study cannot draw a conclusion relating to the optimal conduit for ISR.

2017 ◽  
Vol 41 ◽  
pp. 118-126 ◽  
Author(s):  
Brigitta Lutz ◽  
Christian Reeps ◽  
Gabor Biro ◽  
Christoph Knappich ◽  
Alexander Zimmermann ◽  
...  

2010 ◽  
Vol 25 (2) ◽  
pp. 249-252 ◽  
Author(s):  
Eduardo Dulbecco ◽  
Mariano Camporrotondo ◽  
Gustavo Blanco ◽  
Diego Haberman

Vascular ◽  
2016 ◽  
Vol 24 (6) ◽  
pp. 561-566 ◽  
Author(s):  
AG Krasznai ◽  
MGJ Snoeijs ◽  
MP Siroen ◽  
T Sigterman ◽  
A Korsten ◽  
...  

Currently available conduits for in situ reconstruction after excision of infected aortic grafts have significant limitations. The Omniflow II vascular prosthesis is a biosynthetic graft associated with a low incidence of infection that has succesfully been used in the treatment of infected infrainguinal bypass. We report on the first use of the Omniflow II prosthesis for in situ reconstruction after aortic graft infection. A bifurcated biosynthetic bypass was created by spatulating and anastomosing two 8-mm tubular Omniflow II grafts. This bypass was used for in situ reconstruction after excision of infected aortic grafts in three cases. After a mean follow-up of 2.2 years, no occlusion, degeneration, or rupture of the Omniflow II grafts was observed. Although one patient suffered from graft reinfection, the bypass retained structural integrity and no anastomotic dehiscence was observed. Treatment of aortic graft infection by in situ reconstruction with the Omniflow II vascular prosthesis is feasible. Its resistance to infection and off-the-shelf availability make this graft a promising conduit for aortoiliac reconstruction.


2013 ◽  
Vol 2013 (jul29 1) ◽  
pp. bcr2013010289-bcr2013010289 ◽  
Author(s):  
A. A. Karpenko ◽  
P. V. Ignatenko ◽  
A. M. Beliaev

Angiology ◽  
2017 ◽  
Vol 69 (5) ◽  
pp. 370-379 ◽  
Author(s):  
Michel Batt ◽  
Patrick Feugier ◽  
Fabrice Camou ◽  
Amandine Coffy ◽  
Eric Senneville ◽  
...  

2008 ◽  
Vol 48 (2) ◽  
pp. 503 ◽  
Author(s):  
M. Batt ◽  
E. Jean-Baptiste ◽  
S. O'Connor ◽  
P.-J. Bouillanne ◽  
P. Haudebourg ◽  
...  

Aim: Primary outcome measures was to analyze the clinical consequence of patients who treated for infrarenal aorta synthetic graft infection ( SGI) with extra-anatomical bypass (axillobifemoral (AXF)) or in situ reconstruction (ISR). Secondary outcome measure was to show bacteriological analysis of abdominal aorta graft infection. Method: Analysis of medical records of 24 patients treated for SGI at Jordanian Royal Medical Services between June 2010 and Aug 2020 were retrospectively reviewed. For all patients, we recorded clinical features , morbidity and mortality , as well as bacteriology results, and antibiotic treatment . Result: We identified 24(3%) patients with SGI .The median follow up duration was 22 months range (8-84months). The median age was 52 years and 18 were males. An in situ prosthetic graft replacement, using rifampin-soaked polyester graft was performed in 10 patients(42%) and AXF in 14 patients((58%). The early hospital mortality rate was 4 (17 %.) owing to bowel ischemia 1 patient, 2 patients with septicemia and one patient with aortic stump blowout . There were no late procedure-related deaths during follow up period Primary patency and limb salvage rates at 3 years were 80 %(2 patients ) for ISR and 90%( 2 patients) for AXF. The incidence of graft reinfection was 10% (1 patient) for ISR and 8 %(2 patients) for AXF. Graft reinfection occurred in 3 patients (12.5%) was not associated with procedure-related death .Microbiology specimens obtained from the graft and the tissues were positive in 21 patients(88%). Poly microbial Gram-positive organisms were the most dominant bacteria found in 10 patients (42%). The mean length of hospital stay was 17 days . Conclusion: According to our study ISR and AXF is a safe and effective in treatment of aortic graft infection. Graft reinfection occurred in 12.5% of the patients. The graft patency and limb salvages rates were considered satisfactory.


Sign in / Sign up

Export Citation Format

Share Document